SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-22-074335
Filing Date
2022-11-22
Accepted
2022-11-21 19:31:35
Documents
52
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0922_biotechacq.htm   iXBRL 10-Q 610233
2 CERTIFICATION f10q0922ex31-1_biotechacq.htm EX-31.1 12424
3 CERTIFICATION f10q0922ex31-2_biotechacq.htm EX-31.2 12423
4 CERTIFICATION f10q0922ex32-1_biotechacq.htm EX-32.1 4764
5 CERTIFICATION f10q0922ex32-2_biotechacq.htm EX-32.2 4693
  Complete submission text file 0001213900-22-074335.txt   3401649

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE biot-20220930.xsd EX-101.SCH 49771
7 XBRL CALCULATION FILE biot-20220930_cal.xml EX-101.CAL 21054
8 XBRL DEFINITION FILE biot-20220930_def.xml EX-101.DEF 176920
9 XBRL LABEL FILE biot-20220930_lab.xml EX-101.LAB 362361
10 XBRL PRESENTATION FILE biot-20220930_pre.xml EX-101.PRE 183764
46 EXTRACTED XBRL INSTANCE DOCUMENT f10q0922_biotechacq_htm.xml XML 353098
Mailing Address 545 WEST 25TH STREET 20TH FLOOR NEW YORK NY 10001
Business Address 545 WEST 25TH STREET 20TH FLOOR NEW YORK NY 10001 8586920539
Biotech Acquisition Co (Filer) CIK: 0001825413 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39935 | Film No.: 221407138
SIC: 2834 Pharmaceutical Preparations